All current vaccines require constant updating to keep up with virus mutations. However, they are unlikely to offer the same reliable protection

Real-world data showed that bivalent messenger RNA vaccines against SARS-CoV-2 provided “significant additional protection”

During the COVID-19 pandemic, the volume of services that specialists provide to people via the Internet has increased dramatically around the world

A new Japanese study of highly purified eicosapentaenoic acid (EPA; icosapent ethyl) has suggested a possible benefit in reducing adverse cardiovascular events in patients with chronic coronary artery disease taking statins

This vaccine will also be directed at other strains